Characterizing Circulating microRNA Signatures of Type 2 Diabetes Subtypes

Type 2 diabetes (T2D) is a heterogeneous disease influenced by both genetic and environmental factors. Recent studies suggest that T2D subtypes may exhibit distinct gene expression profiles. In this study, we aimed to identify T2D cluster-specific miRNA expression signatures for the previously repor...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 26; no. 2; p. 637
Main Authors Sulaiman, Fatima, Khyriem, Costerwell, Dsouza, Stafny, Abdul, Fatima, Alkhnbashi, Omer, Faraji, Hanan, Farooqi, Muhammad, Al Awadi, Fatheya, Hassanein, Mohammed, Ahmed, Fayha, Alsharhan, Mouza, Tawfik, Abdel Rahman, Khamis, Amar Hassan, Bayoumi, Riad
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 14.01.2025
MDPI
Subjects
Online AccessGet full text
ISSN1422-0067
1661-6596
1422-0067
DOI10.3390/ijms26020637

Cover

Loading…
Abstract Type 2 diabetes (T2D) is a heterogeneous disease influenced by both genetic and environmental factors. Recent studies suggest that T2D subtypes may exhibit distinct gene expression profiles. In this study, we aimed to identify T2D cluster-specific miRNA expression signatures for the previously reported five clinical subtypes that characterize the underlying pathophysiology of long-standing T2D: severe insulin-resistant diabetes (SIRD), severe insulin-deficient diabetes (SIDD), mild age-related diabetes (MARD), mild obesity-related diabetes (MOD), and mild early-onset diabetes (MEOD). We analyzed the circulating microRNAs (miRNAs) in 45 subjects representing the five T2D clusters and 7 non-T2D healthy controls by single-end small RNA sequencing. Bioinformatic analyses identified a total of 430 known circulating miRNAs and 13 previously unreported novel miRNAs. Of these, 71 were upregulated and 37 were downregulated in either controls or individual clusters. Each T2D subtype was associated with a specific dysregulated miRNA profile, distinct from that of healthy controls. Specifically, 3 upregulated miRNAs were unique to SIRD, 1 to MARD, 9 to MOD, and 18 to MEOD. Among the downregulated miRNAs, 11 were specific to SIRD, 9 to SIDD, 2 to MARD, and 1 to MEOD. Our study confirms the heterogeneity of T2D, represented by distinguishable subtypes both clinically and epigenetically and highlights the potential of miRNAs as markers for distinguishing the pathophysiology of T2D subtypes.
AbstractList Type 2 diabetes (T2D) is a heterogeneous disease influenced by both genetic and environmental factors. Recent studies suggest that T2D subtypes may exhibit distinct gene expression profiles. In this study, we aimed to identify T2D cluster-specific miRNA expression signatures for the previously reported five clinical subtypes that characterize the underlying pathophysiology of long-standing T2D: severe insulin-resistant diabetes (SIRD), severe insulin-deficient diabetes (SIDD), mild age-related diabetes (MARD), mild obesity-related diabetes (MOD), and mild early-onset diabetes (MEOD). We analyzed the circulating microRNAs (miRNAs) in 45 subjects representing the five T2D clusters and 7 non-T2D healthy controls by single-end small RNA sequencing. Bioinformatic analyses identified a total of 430 known circulating miRNAs and 13 previously unreported novel miRNAs. Of these, 71 were upregulated and 37 were downregulated in either controls or individual clusters. Each T2D subtype was associated with a specific dysregulated miRNA profile, distinct from that of healthy controls. Specifically, 3 upregulated miRNAs were unique to SIRD, 1 to MARD, 9 to MOD, and 18 to MEOD. Among the downregulated miRNAs, 11 were specific to SIRD, 9 to SIDD, 2 to MARD, and 1 to MEOD. Our study confirms the heterogeneity of T2D, represented by distinguishable subtypes both clinically and epigenetically and highlights the potential of miRNAs as markers for distinguishing the pathophysiology of T2D subtypes.Type 2 diabetes (T2D) is a heterogeneous disease influenced by both genetic and environmental factors. Recent studies suggest that T2D subtypes may exhibit distinct gene expression profiles. In this study, we aimed to identify T2D cluster-specific miRNA expression signatures for the previously reported five clinical subtypes that characterize the underlying pathophysiology of long-standing T2D: severe insulin-resistant diabetes (SIRD), severe insulin-deficient diabetes (SIDD), mild age-related diabetes (MARD), mild obesity-related diabetes (MOD), and mild early-onset diabetes (MEOD). We analyzed the circulating microRNAs (miRNAs) in 45 subjects representing the five T2D clusters and 7 non-T2D healthy controls by single-end small RNA sequencing. Bioinformatic analyses identified a total of 430 known circulating miRNAs and 13 previously unreported novel miRNAs. Of these, 71 were upregulated and 37 were downregulated in either controls or individual clusters. Each T2D subtype was associated with a specific dysregulated miRNA profile, distinct from that of healthy controls. Specifically, 3 upregulated miRNAs were unique to SIRD, 1 to MARD, 9 to MOD, and 18 to MEOD. Among the downregulated miRNAs, 11 were specific to SIRD, 9 to SIDD, 2 to MARD, and 1 to MEOD. Our study confirms the heterogeneity of T2D, represented by distinguishable subtypes both clinically and epigenetically and highlights the potential of miRNAs as markers for distinguishing the pathophysiology of T2D subtypes.
Type 2 diabetes (T2D) is a heterogeneous disease influenced by both genetic and environmental factors. Recent studies suggest that T2D subtypes may exhibit distinct gene expression profiles. In this study, we aimed to identify T2D cluster-specific miRNA expression signatures for the previously reported five clinical subtypes that characterize the underlying pathophysiology of long-standing T2D: severe insulin-resistant diabetes (SIRD), severe insulin-deficient diabetes (SIDD), mild age-related diabetes (MARD), mild obesity-related diabetes (MOD), and mild early-onset diabetes (MEOD). We analyzed the circulating microRNAs (miRNAs) in 45 subjects representing the five T2D clusters and 7 non-T2D healthy controls by single-end small RNA sequencing. Bioinformatic analyses identified a total of 430 known circulating miRNAs and 13 previously unreported novel miRNAs. Of these, 71 were upregulated and 37 were downregulated in either controls or individual clusters. Each T2D subtype was associated with a specific dysregulated miRNA profile, distinct from that of healthy controls. Specifically, 3 upregulated miRNAs were unique to SIRD, 1 to MARD, 9 to MOD, and 18 to MEOD. Among the downregulated miRNAs, 11 were specific to SIRD, 9 to SIDD, 2 to MARD, and 1 to MEOD. Our study confirms the heterogeneity of T2D, represented by distinguishable subtypes both clinically and epigenetically and highlights the potential of miRNAs as markers for distinguishing the pathophysiology of T2D subtypes.
Audience Academic
Author Alsharhan, Mouza
Al Awadi, Fatheya
Farooqi, Muhammad
Tawfik, Abdel Rahman
Dsouza, Stafny
Ahmed, Fayha
Alkhnbashi, Omer
Abdul, Fatima
Faraji, Hanan
Bayoumi, Riad
Hassanein, Mohammed
Khyriem, Costerwell
Sulaiman, Fatima
Khamis, Amar Hassan
AuthorAffiliation 2 Center for Applied and Translational Genomics, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates; omer.alkhnbashi@dubaihealth.ae
6 Hamdan Bin Mohammed College of Dental Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates; abdel.tawfik@dubaihealth.ae (A.R.T.); amar.hassan@dubaihealth.ae (A.H.K.)
1 College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates; fatima.sulaiman@students.mbru.ac.ae (F.S.); costerwell.khyriem@dubaihealth.ae (C.K.); stafny.dsouza@dubaihealth.ae (S.D.); fatima.abdul@dubaihealth.ae (F.A.); hanan.faraji@students.mbru.ac.ae (H.F.)
5 Pathology Department, Dubai Hospital, Dubai Health, Dubai P.O. Box 7272, United Arab Emirates; faaahmed@dubaihealth.ae (F.A.); maalsharhan@dubaihealth.ae (M.A.)
3 Dubai Diabetes Center, Dubai Health, Dubai P.O. Box 7272, United Arab Emirates; mhfaro
AuthorAffiliation_xml – name: 4 Endocrinology Department, Dubai Hospital, Dubai Health, Dubai P.O. Box 7272, United Arab Emirates; ffalawadi@dubaihealth.ae (F.A.A.); mmhassanein@dubaihealth.ae (M.H.)
– name: 1 College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates; fatima.sulaiman@students.mbru.ac.ae (F.S.); costerwell.khyriem@dubaihealth.ae (C.K.); stafny.dsouza@dubaihealth.ae (S.D.); fatima.abdul@dubaihealth.ae (F.A.); hanan.faraji@students.mbru.ac.ae (H.F.)
– name: 2 Center for Applied and Translational Genomics, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates; omer.alkhnbashi@dubaihealth.ae
– name: 5 Pathology Department, Dubai Hospital, Dubai Health, Dubai P.O. Box 7272, United Arab Emirates; faaahmed@dubaihealth.ae (F.A.); maalsharhan@dubaihealth.ae (M.A.)
– name: 3 Dubai Diabetes Center, Dubai Health, Dubai P.O. Box 7272, United Arab Emirates; mhfarooqi@dubaihealth.ae
– name: 6 Hamdan Bin Mohammed College of Dental Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates; abdel.tawfik@dubaihealth.ae (A.R.T.); amar.hassan@dubaihealth.ae (A.H.K.)
Author_xml – sequence: 1
  givenname: Fatima
  surname: Sulaiman
  fullname: Sulaiman, Fatima
– sequence: 2
  givenname: Costerwell
  orcidid: 0000-0003-2078-2532
  surname: Khyriem
  fullname: Khyriem, Costerwell
– sequence: 3
  givenname: Stafny
  orcidid: 0000-0001-5618-6930
  surname: Dsouza
  fullname: Dsouza, Stafny
– sequence: 4
  givenname: Fatima
  surname: Abdul
  fullname: Abdul, Fatima
– sequence: 5
  givenname: Omer
  orcidid: 0000-0001-8088-590X
  surname: Alkhnbashi
  fullname: Alkhnbashi, Omer
– sequence: 6
  givenname: Hanan
  surname: Faraji
  fullname: Faraji, Hanan
– sequence: 7
  givenname: Muhammad
  orcidid: 0000-0001-6489-3715
  surname: Farooqi
  fullname: Farooqi, Muhammad
– sequence: 8
  givenname: Fatheya
  orcidid: 0000-0001-8911-866X
  surname: Al Awadi
  fullname: Al Awadi, Fatheya
– sequence: 9
  givenname: Mohammed
  surname: Hassanein
  fullname: Hassanein, Mohammed
– sequence: 10
  givenname: Fayha
  orcidid: 0009-0005-2542-9959
  surname: Ahmed
  fullname: Ahmed, Fayha
– sequence: 11
  givenname: Mouza
  surname: Alsharhan
  fullname: Alsharhan, Mouza
– sequence: 12
  givenname: Abdel Rahman
  surname: Tawfik
  fullname: Tawfik, Abdel Rahman
– sequence: 13
  givenname: Amar Hassan
  orcidid: 0000-0002-8518-3066
  surname: Khamis
  fullname: Khamis, Amar Hassan
– sequence: 14
  givenname: Riad
  orcidid: 0000-0001-8177-8129
  surname: Bayoumi
  fullname: Bayoumi, Riad
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39859351$$D View this record in MEDLINE/PubMed
BookMark eNptks1PHCEYxkmj8aveem4m8eKha19gGODUbLa21RhNqj0ThoWVzQysMNNE__qy9aNrYzjw5uHHA-_HPtoKMViEPmA4oVTCZ7_sM2mAQEP5O7SHa0ImAA3f2oh30X7OSwBCCZM7aJdKwSRleA-dz2510mawyT_4sKhmPpmx08M67r1J8efltLr2i6CHMdlcRVfd3K9sRaqvXrd2KNL12A5Fyu_RttNdtodP-wH69e30ZvZjcnH1_Ww2vZiYmvJhIhg1ILSxsm25kY2khmNuKKFO4EZzPq-Z0AyDlUS0kjvcQktYU1Pi9NxxeoC-PPquxra3c2PDkHSnVsn3Ot2rqL16fRL8rVrE3wpj3jQgoTgcPzmkeDfaPKjeZ2O7Tgcbx6woZlIAJgIX9Og_dBnHFEp-fykGgLn8Ry10Z5UPLpaHzdpUTUWpOcZ1vf74yRtUWXNbSl266nzRX134uJnpS4rP7SvAp0egNCrnZN0LgkGtp0NtTgf9AxRuqkk
Cites_doi 10.1002/jev2.12055
10.51847/SKWTZqgB22
10.3390/diagnostics12102275
10.2337/dc16-1354
10.2337/db18-0470
10.1093/nar/gkae456
10.3389/fendo.2022.888948
10.3892/mmr.2017.6239
10.1016/j.cels.2019.03.004
10.1186/1755-8794-3-21
10.3389/fendo.2022.937089
10.1186/s12916-017-0901-x
10.1093/nar/gky1141
10.1016/j.trsl.2022.03.008
10.1093/nar/gkac1072
10.1186/1471-2105-12-480
10.1126/scitranslmed.aaa9364
10.1210/er.2019-00088
10.1007/s00125-022-05769-4
10.1371/annotation/698b7123-174f-4a09-95c9-fd6f5017d622
10.1186/s12889-023-16540-8
10.1016/j.cca.2013.05.021
10.1007/s00125-012-2539-8
10.1101/319509
10.1371/journal.pone.0304036
10.1016/j.bbrc.2018.02.129
10.1111/iwj.14007
10.1093/bioinformatics/btv494
10.4239/wjd.v15.i2.260
10.1155/2023/9663320
10.1038/srep44986
10.1371/journal.pone.0041561
10.1159/000512428
10.1002/dmrr.3005
10.1016/j.xcrm.2021.100477
10.1089/nat.2018.0763
10.1007/s11033-016-4043-6
10.7754/Clin.Lab.2018.181113
10.2337/db17-0141
10.1093/nar/gkp427
10.7150/thno.23334
10.3390/jcm9041220
10.1038/s41587-023-01767-y
10.1038/s41598-019-43793-4
10.1186/1423-0127-20-72
10.1093/nar/gkr688
10.1093/nar/gkac963
10.1186/1755-8794-2-54
10.2337/dc15-S005
10.1002/iub.1970
10.1016/j.ncrna.2024.07.001
10.1515/bmc-2017-0024
10.1016/j.trsl.2018.09.006
10.4239/wjd.v10.i4.241
10.1007/s00125-015-3510-2
10.3389/fendo.2023.1192629
10.1038/nrendo.2009.102
10.1136/bmjdrc-2020-001506
10.1371/journal.pone.0111537
10.1038/nrendo.2013.86
10.1007/s00125-017-4210-x
10.1016/j.diabres.2021.109119
10.3390/ijms18030456
10.3390/ijms21176275
10.1093/nar/gkaa467
10.7754/Clin.Lab.2021.210447
10.1016/S2213-8587(18)30051-2
10.1080/09168451.2015.1107460
10.3390/ijms24032964
10.1016/j.humgen.2023.201191
10.5001/omj.2014.11
10.4238/gmr.15027259
10.1186/s43141-022-00348-x
10.1016/j.tem.2018.03.019
10.1038/ncb2211
10.1371/journal.pone.0128372
10.3390/jcm9072184
10.1007/s00125-019-4909-y
10.4103/ijem.IJEM_162_18
10.1186/s40364-015-0047-y
10.1093/bib/bbac222
10.1186/s12859-019-3105-x
10.2337/diab.43.11.1271
10.1093/cvr/cvq010
10.7150/ijms.10001
10.1111/jcmm.14182
10.1007/s00592-018-1149-4
10.3390/diagnostics11060949
10.1007/978-3-319-24277-4_9
10.1038/s41588-021-00948-2
10.1007/s11010-014-2170-8
ContentType Journal Article
Copyright COPYRIGHT 2025 MDPI AG
2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2025 by the authors. 2025
Copyright_xml – notice: COPYRIGHT 2025 MDPI AG
– notice: 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2025 by the authors. 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M1P
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.3390/ijms26020637
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Publicly Available Content Database
CrossRef

MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1422-0067
ExternalDocumentID PMC11766090
A832511447
39859351
10_3390_ijms26020637
Genre Journal Article
GeographicLocations United Arab Emirates
Middle East
GeographicLocations_xml – name: United Arab Emirates
– name: Middle East
GrantInformation_xml – fundername: Sandooq Al Watan
  grantid: This research was funded by the COLLEGE OF MEDICINE, MOHAMMED BIN RASHID UNI-VERSITY OF MEDICINE AND HEALTH SCIENCES (MBRU), grant Number: MBRU-CM-RG2021-09 and SANDOOQ AL WATAN LLC, grant number: SWARD-F22-013 to R.B. The APC was funded by MBRU, Ph.D. gr
– fundername: SANDOOQ AL WATAN LLC
  grantid: SWARD-F22-013
– fundername: MBRU
  grantid: PhDBMS21
– fundername: COLLEGE OF MEDICINE, MOHAMMED BIN RASHID UNIVERSITY OF MEDICINE AND HEALTH SCIENCES (MBRU)
  grantid: MBRU-CM-RG2021-09
GroupedDBID ---
29J
2WC
53G
5GY
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
8G5
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AFKRA
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1I
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
ESX
F5P
FRP
FYUFA
GNUQQ
GUQSH
GX1
HH5
HMCUK
HYE
IAO
IHR
ITC
KQ8
LK8
M1P
M2O
M48
MODMG
O5R
O5S
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RPM
TR2
TUS
UKHRP
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7XB
8FK
K9.
MBDVC
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c437t-853c08ace9bb7c9693c717c323f816a77d458a510e928b97f1b0b256432fadf73
IEDL.DBID M48
ISSN 1422-0067
1661-6596
IngestDate Thu Aug 21 18:40:37 EDT 2025
Thu Jul 10 23:40:15 EDT 2025
Fri Jul 25 22:26:46 EDT 2025
Tue Jun 17 21:58:24 EDT 2025
Tue Jun 10 20:58:59 EDT 2025
Tue May 06 01:31:52 EDT 2025
Tue Jul 01 02:40:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Type 2 diabetes
T2D subtypes
insulin resistance
circulating microRNA
pathophysiology
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c437t-853c08ace9bb7c9693c717c323f816a77d458a510e928b97f1b0b256432fadf73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-2078-2532
0000-0002-8518-3066
0000-0001-8088-590X
0000-0001-8911-866X
0009-0005-2542-9959
0000-0001-8177-8129
0000-0001-5618-6930
0000-0001-6489-3715
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ijms26020637
PMID 39859351
PQID 3159500179
PQPubID 2032341
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11766090
proquest_miscellaneous_3159801281
proquest_journals_3159500179
gale_infotracmisc_A832511447
gale_infotracacademiconefile_A832511447
pubmed_primary_39859351
crossref_primary_10_3390_ijms26020637
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20250114
PublicationDateYYYYMMDD 2025-01-14
PublicationDate_xml – month: 1
  year: 2025
  text: 20250114
  day: 14
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle International journal of molecular sciences
PublicationTitleAlternate Int J Mol Sci
PublicationYear 2025
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References ref_50
ref_93
Pearson (ref_9) 2019; 62
Anjana (ref_11) 2020; 8
Bijkerk (ref_26) 2019; 29
Hotamisligil (ref_75) 1994; 43
Stidsen (ref_12) 2018; 34
Bodenhofer (ref_92) 2015; 31
Libera (ref_40) 2018; 8
Camargo (ref_45) 2018; 50
Ahlqvist (ref_14) 2018; 6
Zhou (ref_41) 2012; 55
ref_58
ref_57
ref_56
Li (ref_46) 2018; 29
Udler (ref_15) 2019; 40
ref_54
Pokharel (ref_68) 2024; 9
ref_52
Li (ref_13) 2015; 7
Shah (ref_28) 2017; 40
Gluckman (ref_23) 2009; 5
MacKowiak (ref_80) 2012; 40
Aravinda (ref_6) 2019; 10
ref_16
Yan (ref_43) 2014; 397
Dwivedi (ref_17) 2021; 53
Xihua (ref_61) 2019; 205
Xia (ref_51) 2022; 68
Micheloni (ref_21) 2018; 55
ref_60
Grieco (ref_32) 2022; 247
Lu (ref_64) 2010; 86
Gautam (ref_30) 2016; 43
Kozomara (ref_82) 2019; 47
ref_65
ref_20
Elizarraras (ref_90) 2024; 52
Tian (ref_76) 2018; 73
ref_29
Woodhouse (ref_79) 2014; 29
Shaker (ref_33) 2019; 71
Song (ref_62) 2018; 497
Sun (ref_55) 2023; 20
Deutsch (ref_18) 2022; 65
Sun (ref_2) 2022; 183
ref_71
Guay (ref_31) 2013; 9
Hao (ref_87) 2024; 42
Sucharita (ref_25) 2018; 22
ref_36
ref_35
ref_34
ref_78
ref_77
ref_74
Hassanein (ref_5) 2020; 26
Zhu (ref_24) 2015; 58
McCarthy (ref_10) 2017; 60
Chang (ref_88) 2020; 48
Brorsson (ref_19) 2022; 3
ref_39
Massart (ref_48) 2017; 66
ref_37
Nassar (ref_81) 2023; 51
Rozowsky (ref_85) 2019; 8
Yang (ref_59) 2019; 65
ref_83
Kanehisa (ref_91) 2023; 51
Wu (ref_8) 2014; 11
Ghai (ref_49) 2019; 23
Abbas (ref_73) 2023; 37
ref_89
ref_44
Li (ref_27) 2021; 10
ref_42
ref_86
Jordan (ref_63) 2011; 13
Guo (ref_47) 2023; 2023
ref_84
ref_1
Morales (ref_22) 2017; 8
He (ref_53) 2024; 15
ref_3
Chen (ref_72) 2009; 37
Yamada (ref_70) 2013; 424
Yang (ref_66) 2017; 15
Mohamed (ref_67) 2022; 13
ref_4
Ding (ref_69) 2016; 80
ref_7
Katayama (ref_38) 2019; 68
References_xml – volume: 10
  start-page: e12055
  year: 2021
  ident: ref_27
  article-title: Pancreatic β cells control glucose homeostasis via the secretion of exosomal miR-29 family
  publication-title: J. Extracell. Vesicles
  doi: 10.1002/jev2.12055
– volume: 13
  start-page: 137
  year: 2022
  ident: ref_67
  article-title: MicroRNA-224 Up-regulation: A Risk for Complications in Type 2 Diabetes Mellitus Egyptian Patients
  publication-title: Pharmacophore
  doi: 10.51847/SKWTZqgB22
– ident: ref_52
  doi: 10.3390/diagnostics12102275
– volume: 40
  start-page: 546
  year: 2017
  ident: ref_28
  article-title: Extracellular RNAs are associated with insulin resistance and metabolic phenotypes
  publication-title: Diabetes Care
  doi: 10.2337/dc16-1354
– volume: 68
  start-page: 515
  year: 2019
  ident: ref_38
  article-title: Circulating Exosomal miR-20b-5p Is Elevated in Type 2 Diabetes and Could Impair Insulin Action in Human Skeletal Muscle
  publication-title: Diabetes
  doi: 10.2337/db18-0470
– volume: 52
  start-page: W415
  year: 2024
  ident: ref_90
  article-title: WebGestalt 2024: Faster gene set analysis and new support for metabolomics and multi-omics
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkae456
– ident: ref_56
  doi: 10.3389/fendo.2022.888948
– volume: 15
  start-page: 2143
  year: 2017
  ident: ref_66
  article-title: Serum microRNA profiling and bioinformatics analysis of patients with type 2 diabetes mellitus in a Chinese population
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr.2017.6239
– volume: 8
  start-page: 352
  year: 2019
  ident: ref_85
  article-title: exceRpt: A Comprehensive Analytic Platform for Extracellular RNA Profiling
  publication-title: Cell Syst.
  doi: 10.1016/j.cels.2019.03.004
– ident: ref_86
  doi: 10.1186/1755-8794-3-21
– ident: ref_57
  doi: 10.3389/fendo.2022.937089
– ident: ref_7
  doi: 10.1186/s12916-017-0901-x
– volume: 47
  start-page: D155
  year: 2019
  ident: ref_82
  article-title: miRBase: From microRNA sequences to function
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gky1141
– volume: 247
  start-page: 137
  year: 2022
  ident: ref_32
  article-title: Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside
  publication-title: Transl. Res.
  doi: 10.1016/j.trsl.2022.03.008
– volume: 51
  start-page: D1188
  year: 2023
  ident: ref_81
  article-title: The UCSC Genome Browser database: 2023 update
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkac1072
– ident: ref_83
  doi: 10.1186/1471-2105-12-480
– volume: 7
  start-page: 311ra174
  year: 2015
  ident: ref_13
  article-title: Identification of type 2 diabetes subgroups through topological analysis of patient similarity
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aaa9364
– volume: 40
  start-page: 1500
  year: 2019
  ident: ref_15
  article-title: Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine
  publication-title: Endocr. Rev.
  doi: 10.1210/er.2019-00088
– volume: 65
  start-page: 1758
  year: 2022
  ident: ref_18
  article-title: Phenotypic and genetic classification of diabetes
  publication-title: Diabetologia
  doi: 10.1007/s00125-022-05769-4
– ident: ref_34
  doi: 10.1371/annotation/698b7123-174f-4a09-95c9-fd6f5017d622
– ident: ref_4
  doi: 10.1186/s12889-023-16540-8
– volume: 424
  start-page: 99
  year: 2013
  ident: ref_70
  article-title: Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver
  publication-title: Clin. Chim. Acta
  doi: 10.1016/j.cca.2013.05.021
– volume: 55
  start-page: 2032
  year: 2012
  ident: ref_41
  article-title: Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity
  publication-title: Diabetologia
  doi: 10.1007/s00125-012-2539-8
– ident: ref_16
  doi: 10.1101/319509
– ident: ref_20
  doi: 10.1371/journal.pone.0304036
– volume: 497
  start-page: 667
  year: 2018
  ident: ref_62
  article-title: MiR-29 family members interact with SPARC to regulate glucose metabolism
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2018.02.129
– volume: 20
  start-page: 1525
  year: 2023
  ident: ref_55
  article-title: A gene chip study suggests that miR-17-3p is associated with diabetic foot ulcers
  publication-title: Int. Wound J.
  doi: 10.1111/iwj.14007
– volume: 31
  start-page: 3997
  year: 2015
  ident: ref_92
  article-title: Msa: An R package for multiple sequence alignment
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btv494
– volume: 15
  start-page: 260
  year: 2024
  ident: ref_53
  article-title: Long noncoding RNA protein-disulfide isomerase-associated 3 regulated high glucose-induced podocyte apoptosis in diabetic nephropathy through targeting miR-139-3p
  publication-title: World J. Diabetes
  doi: 10.4239/wjd.v15.i2.260
– volume: 2023
  start-page: 9663320
  year: 2023
  ident: ref_47
  article-title: Expression and Clinical Significance of Plasma miR-223 in Patients with Diabetic Nephropathy
  publication-title: Int. J. Endocrinol.
  doi: 10.1155/2023/9663320
– ident: ref_50
  doi: 10.1038/srep44986
– ident: ref_29
  doi: 10.1371/journal.pone.0041561
– volume: 26
  start-page: 164
  year: 2020
  ident: ref_5
  article-title: Prevalence of Diabetes and Associated Health Risk Factors among Adults in Dubai, United Arab Emirates: Results from Dubai Household Survey 2019
  publication-title: Dubai Diabetes Endocrinol. J.
  doi: 10.1159/000512428
– volume: 34
  start-page: e3005
  year: 2018
  ident: ref_12
  article-title: Pathophysiology-based phenotyping in type 2 diabetes: A clinical classification tool
  publication-title: Diabetes Metab. Res. Rev.
  doi: 10.1002/dmrr.3005
– volume: 3
  start-page: 100477
  year: 2022
  ident: ref_19
  article-title: Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study
  publication-title: Cell Rep. Med.
  doi: 10.1016/j.xcrm.2021.100477
– volume: 29
  start-page: 67
  year: 2019
  ident: ref_26
  article-title: In Vivo Silencing of MicroRNA-132 Reduces Blood Glucose and Improves Insulin Secretion
  publication-title: Nucleic Acid Ther.
  doi: 10.1089/nat.2018.0763
– volume: 43
  start-page: 1165
  year: 2016
  ident: ref_30
  article-title: Identification of extracellular miRNA in archived serum samples by next-generation sequencing from RNA extracted using multiple methods
  publication-title: Mol. Biol. Rep.
  doi: 10.1007/s11033-016-4043-6
– volume: 65
  start-page: 1015
  year: 2019
  ident: ref_59
  article-title: Peripheral blood miR-937 may serve as a biomarker for metabolic disorders by targeting AMPKα
  publication-title: Clin. Lab.
  doi: 10.7754/Clin.Lab.2018.181113
– volume: 66
  start-page: 1807
  year: 2017
  ident: ref_48
  article-title: Altered miR-29 Expression in Type 2 Diabetes Influences Glucose and Lipid Metabolism in Skeletal Muscle
  publication-title: Diabetes
  doi: 10.2337/db17-0141
– volume: 73
  start-page: 477
  year: 2018
  ident: ref_76
  article-title: MiR-486-5p regulates pancreatic β cell function in type 2 diabetes mellitus by targeting PTEN and FOXO1
  publication-title: Die Pharm.-Int. J. Pharm. Sci.
– volume: 37
  start-page: W305
  year: 2009
  ident: ref_72
  article-title: ToppGene Suite for gene list enrichment analysis and candidate gene prioritization
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkp427
– volume: 8
  start-page: 3874
  year: 2018
  ident: ref_40
  article-title: Circulating ectosomes: Determination of angiogenic microRNAs in type 2 diabetes
  publication-title: Theranostics
  doi: 10.7150/thno.23334
– ident: ref_54
  doi: 10.3390/jcm9041220
– volume: 42
  start-page: 293
  year: 2024
  ident: ref_87
  article-title: Dictionary learning for integrative, multimodal and scalable single-cell analysis
  publication-title: Nat. Biotechnol.
  doi: 10.1038/s41587-023-01767-y
– ident: ref_77
  doi: 10.1038/s41598-019-43793-4
– ident: ref_71
  doi: 10.1186/1423-0127-20-72
– volume: 40
  start-page: 37
  year: 2012
  ident: ref_80
  article-title: miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkr688
– volume: 51
  start-page: D587
  year: 2023
  ident: ref_91
  article-title: KEGG for taxonomy-based analysis of pathways and genomes
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkac963
– ident: ref_65
  doi: 10.1186/1755-8794-2-54
– ident: ref_78
  doi: 10.2337/dc15-S005
– volume: 71
  start-page: 310
  year: 2019
  ident: ref_33
  article-title: Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy
  publication-title: IUBMB Life
  doi: 10.1002/iub.1970
– volume: 9
  start-page: 1324
  year: 2024
  ident: ref_68
  article-title: Evaluation of circulating plasma miR-9, miR-29a, miR-192, and miR-375 as potential biomarkers for predicting prediabetes and type 2 diabetes in Nepali adult population
  publication-title: Noncoding RNA Res.
  doi: 10.1016/j.ncrna.2024.07.001
– volume: 8
  start-page: 203
  year: 2017
  ident: ref_22
  article-title: Epigenetic regulation mechanisms of microRNA expression
  publication-title: Biomol. Concepts
  doi: 10.1515/bmc-2017-0024
– volume: 205
  start-page: 33
  year: 2019
  ident: ref_61
  article-title: Circulating miR-143-3p inhibition protects against insulin resistance in Metabolic Syndrome via targeting of the insulin-like growth factor 2 receptor
  publication-title: Transl. Res.
  doi: 10.1016/j.trsl.2018.09.006
– volume: 10
  start-page: 241
  year: 2019
  ident: ref_6
  article-title: Risk factors in patients with type 2 diabetes in Bengaluru: A retrospective study
  publication-title: World J. Diabetes
  doi: 10.4239/wjd.v10.i4.241
– volume: 58
  start-page: 900
  year: 2015
  ident: ref_24
  article-title: Identification of microRNA biomarkers in type 2 diabetes: A meta-analysis of controlled profiling studies
  publication-title: Diabetologia
  doi: 10.1007/s00125-015-3510-2
– ident: ref_3
  doi: 10.3389/fendo.2023.1192629
– volume: 5
  start-page: 401
  year: 2009
  ident: ref_23
  article-title: Epigenetic mechanisms that underpin metabolic and cardiovascular diseases
  publication-title: Nat. Rev. Endocrinol.
  doi: 10.1038/nrendo.2009.102
– volume: 50
  start-page: 12
  year: 2018
  ident: ref_45
  article-title: A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: From the CORDIOPREV study
  publication-title: Exp. Mol. Med.
– volume: 8
  start-page: e001506
  year: 2020
  ident: ref_11
  article-title: Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: A data-driven cluster analysis: The INSPIRED study
  publication-title: BMJ Open Diabetes Res. Care
  doi: 10.1136/bmjdrc-2020-001506
– ident: ref_74
  doi: 10.1371/journal.pone.0111537
– volume: 9
  start-page: 513
  year: 2013
  ident: ref_31
  article-title: Circulating microRNAs as novel biomarkers for diabetes mellitus
  publication-title: Nat. Rev. Endocrinol.
  doi: 10.1038/nrendo.2013.86
– volume: 60
  start-page: 793
  year: 2017
  ident: ref_10
  article-title: Painting a new picture of personalised medicine for diabetes
  publication-title: Diabetologia
  doi: 10.1007/s00125-017-4210-x
– volume: 183
  start-page: 109119
  year: 2022
  ident: ref_2
  article-title: IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
  publication-title: Diabetes Res. Clin. Pract.
  doi: 10.1016/j.diabres.2021.109119
– ident: ref_37
  doi: 10.3390/ijms18030456
– ident: ref_1
  doi: 10.3390/ijms21176275
– volume: 48
  start-page: W244
  year: 2020
  ident: ref_88
  article-title: miRNet 2.0: Network-based visual analytics for miRNA functional analysis and systems biology
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkaa467
– volume: 68
  start-page: 689
  year: 2022
  ident: ref_51
  article-title: Plasma Levels and Diagnostic Significance of miR-335-3p and EGFR in Diabetic Retinopathy
  publication-title: Clin. Lab.
  doi: 10.7754/Clin.Lab.2021.210447
– volume: 6
  start-page: 361
  year: 2018
  ident: ref_14
  article-title: Novel subgroups of adult-onset diabetes and their association with outcomes: A data-driven cluster analysis of six variables
  publication-title: Lancet Diabetes Endocrinol.
  doi: 10.1016/S2213-8587(18)30051-2
– volume: 80
  start-page: 461
  year: 2016
  ident: ref_69
  article-title: Identification of the differential expression of serum microRNA in type 2 diabetes
  publication-title: Biosci. Biotechnol. Biochem.
  doi: 10.1080/09168451.2015.1107460
– ident: ref_60
  doi: 10.3390/ijms24032964
– volume: 37
  start-page: 201191
  year: 2023
  ident: ref_73
  article-title: Expression of microRNAs 30, 451, 130, and 378 and its relationship to type 1 diabetes mellitus in Egyptian children
  publication-title: Hum. Gene
  doi: 10.1016/j.humgen.2023.201191
– volume: 29
  start-page: 51
  year: 2014
  ident: ref_79
  article-title: Familial Clustering of Type 2 Diabetes among Omanis
  publication-title: Oman Med. J.
  doi: 10.5001/omj.2014.11
– ident: ref_36
  doi: 10.4238/gmr.15027259
– ident: ref_39
  doi: 10.1186/s43141-022-00348-x
– volume: 29
  start-page: 380
  year: 2018
  ident: ref_46
  article-title: A Novel Regulator of Type II Diabetes: MicroRNA-143
  publication-title: Trends Endocrinol. Metab.
  doi: 10.1016/j.tem.2018.03.019
– volume: 13
  start-page: 434
  year: 2011
  ident: ref_63
  article-title: Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism
  publication-title: Nat. Cell. Biol.
  doi: 10.1038/ncb2211
– ident: ref_44
  doi: 10.1371/journal.pone.0128372
– ident: ref_58
  doi: 10.3390/jcm9072184
– volume: 62
  start-page: 1107
  year: 2019
  ident: ref_9
  article-title: Type 2 diabetes: A multifaceted disease
  publication-title: Diabetologia
  doi: 10.1007/s00125-019-4909-y
– volume: 22
  start-page: 770
  year: 2018
  ident: ref_25
  article-title: The Role of Circulating MicroRNA in the Regulation of Beta Cell Function and Insulin Resistance among Indians with Type 2 Diabetes
  publication-title: Indian J. Endocrinol. Metab.
  doi: 10.4103/ijem.IJEM_162_18
– ident: ref_42
  doi: 10.1186/s40364-015-0047-y
– ident: ref_93
  doi: 10.1093/bib/bbac222
– ident: ref_89
  doi: 10.1186/s12859-019-3105-x
– volume: 43
  start-page: 1271
  year: 1994
  ident: ref_75
  article-title: Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link
  publication-title: Diabetes
  doi: 10.2337/diab.43.11.1271
– volume: 86
  start-page: 410
  year: 2010
  ident: ref_64
  article-title: MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism
  publication-title: Cardiovasc. Res.
  doi: 10.1093/cvr/cvq010
– volume: 11
  start-page: 1185
  year: 2014
  ident: ref_8
  article-title: Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention
  publication-title: Int. J. Med. Sci.
  doi: 10.7150/ijms.10001
– volume: 23
  start-page: 2753
  year: 2019
  ident: ref_49
  article-title: Circulating RNAs as predictive markers for the progression of type 2 diabetes
  publication-title: J. Cell Mol. Med.
  doi: 10.1111/jcmm.14182
– volume: 55
  start-page: 989
  year: 2018
  ident: ref_21
  article-title: Novel insights into the regulation of miRNA transcriptional control: Implications for T2D and related complications
  publication-title: Acta Diabetol.
  doi: 10.1007/s00592-018-1149-4
– ident: ref_35
  doi: 10.3390/diagnostics11060949
– ident: ref_84
  doi: 10.1007/978-3-319-24277-4_9
– volume: 53
  start-page: 1534
  year: 2021
  ident: ref_17
  article-title: Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes
  publication-title: Nat. Genet.
  doi: 10.1038/s41588-021-00948-2
– volume: 397
  start-page: 45
  year: 2014
  ident: ref_43
  article-title: MiR-199a is overexpressed in plasma of type 2 diabetes patients which contributes to type 2 diabetes by targeting GLUT4
  publication-title: Mol. Cell Biochem.
  doi: 10.1007/s11010-014-2170-8
SSID ssj0023259
Score 2.4279854
Snippet Type 2 diabetes (T2D) is a heterogeneous disease influenced by both genetic and environmental factors. Recent studies suggest that T2D subtypes may exhibit...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 637
SubjectTerms Adult
Aged
Analysis
Biomarkers - blood
Body mass index
Case-Control Studies
Circulating MicroRNA - blood
Circulating MicroRNA - genetics
Cluster analysis
Computational Biology - methods
Diabetes
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - classification
Diabetes Mellitus, Type 2 - genetics
Disease
DNA methylation
Drugs
Epigenetics
Expatriates
Fasting
Female
Gene expression
Gene Expression Profiling
Genes
Genomes
Glucose
Humans
Insulin
Insulin resistance
Insulin Resistance - genetics
Male
Metabolism
MicroRNA
MicroRNAs
MicroRNAs - blood
MicroRNAs - genetics
Middle Aged
Pathophysiology
Patients
RNA sequencing
Transcriptome
Type 2 diabetes
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEA66IngR366uEkHxFGybtGlOsiyKCHrwAXsrSZroCnbVrgf99c603XXrwVthprTMJPPNJMM3hBzjTZF0PmFKe86EdiFTKrYs0N4YHUMB7fBG9-Y2uXoU18N42By4lU1b5TQmVoE6H1s8Iz_jgLsxxlR1_vbOcGoU3q42IzQWyRJSl2FLlxz-Flw8qoalhYBBLIlVUje-cyjzz0YvryWk8hEgtGxB0t_APIdM7a7JORi6XCOrTf5I-7XD18mCKzbIcj1R8muTXA9mBMzfAEp0MPqw1YAueH7F3ru72z69Hz3VfJ4lHXuKlSiNaNMaU1IIJXguW26Rx8uLh8EVa8YlMCu4nDAAXhuk2jpljLQqUdxCrWZ5xH0aJlrKXMSphj3oVJQaJX1oAgMZj-CR17mXfJt0inHhdgnVPk9zSFWM40ZwrVKtIRPIlTYqVjo1XXIytVj2VrNiZFBNoGWzect2ySmaM8PNAjazuun5h68g7VTWh3gCGZ8QoNlracIit23x1CFZs8nK7HdJdMnRTIxvYuNY4caftU4FwmGX7NT-m_0xV0j2FoMkbXl2poDU221JMXquKLhD5NUMVLD3_3_tk5UI5wUHIQtFj3QmH5_uAJKYiTmsVuoP4gbwhA
  priority: 102
  providerName: ProQuest
Title Characterizing Circulating microRNA Signatures of Type 2 Diabetes Subtypes
URI https://www.ncbi.nlm.nih.gov/pubmed/39859351
https://www.proquest.com/docview/3159500179
https://www.proquest.com/docview/3159801281
https://pubmed.ncbi.nlm.nih.gov/PMC11766090
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED_tQ6C9oPEdGFWQQDwFktip7QeEumplmrQKDSr1LbIdm3ViKTSdxPjruWs-1ABPvFSRfFaqO9u_38Wn3wG8opsi4fwwUtqziGuXREplNoq1N0ZnmEA7utE9nw5PZ_xsns13oO022jiw-mdqR_2kZqtvb3_-uP2AG_49ZZyYsr9bXF1XSMtTRFuxC_uISYK26Dnv7hOQNmSqLnv_a8YB3GWKVL-ypIdNf57QWxDVL5_cwqPJIdxriGQ4qiN_H3Zc-QDu1K0lbx_C2bhTYv6F6BSOFyu76dSFz9dUhHcxHYWfF19rYc8qXPqQUtIwDZsamSrEM4U-0FaPYDY5-TI-jZq-CZHlTKwjRGAbS22dMkZYNVTMYtJmWcq8TIZaiIJnUuNmdCqVRgmfmNgg9eEs9brwgj2GvXJZuqcQal_IAjmLccxwppXUGilBobRRmdLSBPC69Vj-vZbHyDGtICfn204O4A25M6c4os-sbor_8S2kP5WP8GBB6sc5Wh71LHG12_5wG5C8XSw5Q06WEd6qAF52wzSTKshKt7ypbTZonATwpI5f94_b-Acge5HtDEiDuz9SLi43WtwJCWzGKn72_1Ofw0FKTYXjJEr4EeytVzfuBTKdtRnArpgL_JWTjwPYPz6ZfroYEPZkg83y_g287gMy
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgQXxLMsFDASFSerSZzE8aFCq4Vq-9oDtNLegu3Y7SI1W5qtUPlR_MbO5LHdcODWWyQ7iTWvb8YezwB8pJMi6XzKlfaCx9qFXKnE8kB7Y3SCAbSjE92jSTo-ifenyXQN_nZ3YSitsrOJtaEu5pb2yLcF4m5CNlV9vvjFqWsUna52LTQasThw178xZKt29r4gf7eiaPfr8WjM264C3MZCLjjikw0ybZ0yRlqVKmExpLEiEj4LUy1lESeZRlF1KsqMkj40gUHHIBaR14WXAr97D-4j8AakUXJ6G-CJqG7OFiLm8TRRaZNoL4QKtmc_zysMHSL0CGQPAv8FghUk7GdprsDe7hN43PqrbNgI2FNYc-UzeNB0sLx-DvujZcHnPwiCbDS7tHVDMHw-p1y_b5Mh-z47beqHVmzuGUW-LGJtKk7F0HTRPnD1Ak7uhJAvYb2cl-4VMO2LrEDXyDhhYqFVpjV6HoXSRiVKZ2YAWx3F8oumCkeO0QtRNl-l7AA-ETlzUk6kmdXtHQP8C5W5yodov9DDjGOcudmbiUpl-8MdQ_JWqav8VgQH8GE5TG9Solrp5lfNnBr0wwFsNPxbrlgoKi6X4EjW4-xyApX67o-Us7O65HdIdTwDFbz-_7rew8Px8dFhfrg3OXgDjyLqVRyEPIw3YX1xeeXeogO1MO9qqWXw467V5AbvhCyY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFSKQFwq3iwUMBIVJ2uTOInjA6pWW1Z9wAoBlfYWbMeGRWq2NFtV5dP4us7ksd1w4NZbpJkk1rzHHs8AvKWTIul8ypX2gsfahVypxPJAe2N0ggm0oxPdT9N0_zg-nCWzDfjb3YWhssrOJtaGulhY2iMfCvS7CdlUNfRtWcTnvcnu6W9OE6TopLUbp9GIyJG7vMD0rXp_sIe83omiyYdv433eThjgNhZyydFX2SDT1iljpFWpEhbTGysi4bMw1VIWcZJpFFunoswo6UMTGAwSYhF5XXgp8Lu34LYUSUg6JmfXyZ6I6kFtIfo_niYqbYruhVDBcP7rpMI0IsLoQPbc4b9OYc0r9is211zg5D5stbErGzXC9gA2XPkQ7jTTLC8fweF41fz5DzpENp6f2Xo4GD6fUN3fl-mIfZ3_aHqJVmzhGWXBLGJtWU7F0IzRnnD1GI5vhJBPYLNclO4ZMO2LrMAwyThhYqFVpjVGIYXSRiVKZ2YAOx3F8tOmI0eOmQxRNl-n7ADeETlzUlSkmdXtfQP8C7W8ykdoyzDajGPE3O5hooLZPrhjSN4qeJVfi-MA3qzA9CYVrZVucd7g1AFAOICnDf9WKxaKGs0lCMl6nF0hUNvvPqSc_6zbf4fU0zNQwfP_r-s13EUFyT8eTI9ewL2IxhYHIQ_jbdhcnp27lxhLLc2rWmgZfL9pLbkC3Uswzg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterizing+Circulating+microRNA+Signatures+of+Type+2+Diabetes+Subtypes&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Sulaiman%2C+Fatima&rft.au=Khyriem%2C+Costerwell&rft.au=Dsouza%2C+Stafny&rft.au=Abdul%2C+Fatima&rft.date=2025-01-14&rft.pub=MDPI&rft.eissn=1422-0067&rft.volume=26&rft.issue=2&rft_id=info:doi/10.3390%2Fijms26020637&rft_id=info%3Apmid%2F39859351&rft.externalDocID=PMC11766090
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon